Showing 11-20 of 1704 results for ""
International Experts Advance Clinical Adoption of Islet Cell Therapies at Breakthrough T1D HQ
Islet cell therapies for type 1 diabetes (T1D) replace destroyed insulin-producing beta cells with functional cells that allow the body to make insulin again. To ensure there are enough islet cells for everyone with T1D who wants them, Breakthrough T1D is prioritizing manufactured cell therapies, which can be made in large quantities in a laboratory, […]
Protected: DRAFT Ford Motor Company
There is no excerpt because this is a protected post.
Protected: DRAFT Novo Nordisk
There is no excerpt because this is a protected post.
Protected: DRAFT Sanofi
There is no excerpt because this is a protected post.
Protected: DRAFT Patient Education Resources
There is no excerpt because this is a protected post.
Balancing Mental Health and Type 1 Diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and taking your insulin.
C-peptide: Everything You Need to Know
It was identified in the late 1960s. Since then, studies have shown that it is a biomarker for beta cell function. In other words, it’s a measure of beta cell health and insulin production. If it’s low (or you have none), it indicates that your pancreas is producing little or no insulin. There was even […]
Tzield Approved for Children Ages One and Older in Stage 2 T1D
What’s happening? The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. This is a huge win for the T1D community! Breakthrough T1D applauds the FDA for this approval and Sanofi for their commitment to new therapies for the T1D […]
Protected: DRAFT T1D and Alcohol SEO
There is no excerpt because this is a protected post.
Two Highly Engaged Volunteer Leaders Elected to Head Breakthrough T1D’s International Board of Directors
Karen Shishino Jordan, a long-time volunteer leader in the greater California Bay area, will serve as Breakthrough T1D (formerly JDRF) International Board of Directors (IBOD) Chair, succeeding current Chair Lisa Fishbone Wallack. Carlton McMillan, also a dedicated volunteer leader in the greater California Bay area, will serve as Vice Chair, succeeding current Vice Chair Matt Varey. Karen’s and Carlton’s terms as Chair and Vice Chair, respectively, begin Wednesday, July 1, 2026. Breakthrough […]
